Alnylam Scientists Present Pre-clinical Data with ALN-CC5, an RNAi Therapeutic

News   Jun 21, 2013

 
Alnylam Scientists Present Pre-clinical Data with ALN-CC5, an RNAi Therapeutic
 
 
 

RELATED ARTICLES

BC Platforms Announces Collaborations in Multiple Sclerosis Research

News

Company's technology and research platforms used to better understand genetic basis of MS.

READ MORE

QIAGEN and CENTOGENE to Collaborate in Bioinformatics for Genetic Diseases

News

Aiding the analysis of hereditary disorders by integrating genomic and clinical databases.

READ MORE

Double Helix Technologies teams-up with Agilent Technologies

News

Collaboration will offer the SureVector cloning system for next-generation cloning.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE